$0.293
+0.014 (+4.64%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de HRTX por análisis de gráficos similares
Alphio's HRTX stock price prediction model matches the current Heron Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.29 (-0.65%). The 1-week path is $0.27 (-8.61%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Heron Therapeutics Inc?
Heron Therapeutics Inc is not a good buy right now due to significant financial losses and a low current price of $0.2951, which is near its 52-week low of $0.26. The company reported a net loss of $5.49 million in Q2 2026, and its forward P/E ratio is high at 46.95, indicating that the stock may be overvalued at this time. Additionally, the RSI is at 39.15, suggesting the stock is nearing oversold territory but not yet a strong buy signal. The main risk is the ongoing litigation regarding its CINVANTI patents, which has already led to a significant drop in stock price and could continue to impact future performance.
HRTX cerró en $0.29 el Friday, tras subir +4.64%
Heron Therapeutics Inc (HRTX) last closed at $0.293, gaining +4.64%. These facts feed the 1-day and 1-week HRTX price prediction above.
Consenso de analistas
Heron Therapeutics Inc (HRTX): 11 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Heron Therapeutics Inc (HRTX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de HRTX, ordenadas por similitud.
Análisis de estacionalidad de HRTX
Historically the probability of a positive November return for HRTX is 0.00%. February offers the highest probability of a positive month at 75.86%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de HRTX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $2.29 | $2.32 | $2.43 | +691.77% |
| Dec 2026 | $1.66 | $1.91 | $2.09 | +551.82% |
En 2026, se proyecta que Heron Therapeutics Inc (HRTX) oscile entre $1.66 y $2.43.
Previsión mensual de Heron Therapeutics Inc para 2026
En Nov de 2026, se proyecta que Heron Therapeutics Inc promedie $2.32, con un mínimo de $2.29 y un máximo de $2.43.
En Dec de 2026, se proyecta que Heron Therapeutics Inc promedie $1.91, con un mínimo de $1.66 y un máximo de $2.09.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.